Skip to main content
. 2025 Sep 23;410(1):274. doi: 10.1007/s00423-025-03869-4

Table 3.

Patient’s history

All patients (n = 195) Bleeding complications (N = 35) No bleeding complications (N = 160) p-value
Insulin dependent diabetes mellitus N (%) 51 (26) 12 (34) 39 (24) 0.227
Medication for arterial hypertonus N (%) 103 (53) 22 (63) 1 (51) 0.189
History of thrombosis/embolism N (%) 0.237
Venous thrombosis 6 (3) 0 (0) 6 (4)
Lung artery embolism 6 (3) 0 (0) 6 (4)
Coronary heart disease/PAD 14 (7) 3 (9) 11 (7)
Ischemic stroke 4 (2) 2 (6) 2 (1)
History of bleeding N (%) 4 (2) 0 (0) 4 (3) 0.345
History of liver disease N (%) 13 (7) 2 (6) 11 (7) 0.803
History of alcohol abuse N (%) 20 (10) 3 (9) 17 (11) 0.717
Preoperative anticoagulation N (%) 0.501
Platelet aggregation inhibitor 23 (12) 4 (11) 19 (12)
Coumarine derivatives 3 (2) 1 (3) 2 (1)
Other oral anticoagulation 6 (3) 1 (3) 5 (3)
Other 4 (2) 2 (6) 2 (1)

PAD: peripheral artery disease